Zacks Investment Research on MSN
PacBio stock dips post latest launch to expand multiomics capabilities
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, ...
Our preliminary revenue for the first quarter met our expectations despite impacts from ongoing uncertainty in NIH funding in the United States and broader economic headwinds affecting the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback